The biotech will use the proceeds to develop inhalable versions of therapies already on the market for the “idiopathic” and ...

Tim Boreham chats with Clayton Howes, Managing Director, CEO and founder MONEYME. ... Read More The post Stock Insiders ...

Prominent biotech Biogen ( BIIB +5.94%) loomed large on the stock market on Wednesday. It published its latest set of ...

Apple co-founder Steve Wozniak and former NBA star Dwayne Wade appeared at a multi-day product launch event at the Palace of ...

GeoVax CEO David Dodd highlights the need for U.S. manufacturing to reduce reliance on foreign biotech and strengthen ...

Frontier Scientific Solutions has committed close to a billion dollars in infrastructure at the Wilmington Airport, with ...

A leading Mass. biotech company opened a much anticipated lab and processing space. Here's what it looks like.

Biogen lowered its earnings guidance and projected weaker revenue for 2026, tempering the impact of a first-quarter rise in both sales and profit.

The biotechnical research at the HudsonAlpha Institute for Biotechnology is once again in the national spotlight. The ...

Through two pioneering studies, Amgen and AstraZeneca will share study data with FDA scientists as it’s accrued. Elsewhere, ...

Chiesi Group will acquire KalVista Pharmaceuticals for $1.9B after its FDA approval in July 2025 for an oral hereditary ...

Chiesi Group is taking KalVista Pharmaceuticals under its wing, paying $1.9 billion for the biotech’s oral therapy Ekterly to ...